medline.ch Respirationstrakt Neoplasie

	Construction and Validation of a Risk Prediction Model for Cancer-Related Cognitive Impairment in Lung Cancer Patients. Int J Nurs Pract Qiao M, Luo L, Zhang H. PMID: 42560001 [PubMed - indexed for MEDLINE]
	Diabetes Increases Immunotherapy-Related Toxicity but Not Efficacy in Metastatic Non-Small Cell Lung Cancer: A Multicenter Retrospective Study. Int J Cancer Çak, Divriklio, Güven DC, Özel GS, Y, Emin G, Keskink, A, Balç, Kolk, Do, , Yal, , Danac, Düzköprü Y, Y, Y, Hac, Erdo, K, Do, Ery, Y, Öztop , Bayo, Uzunta, Erdo, Çelik E, Çabuk D, , Öcal ZS, Demir H. PMID: 42559769 [PubMed - as supplied by publisher]
	Cancer-associated fibroblasts in the lung cancer microenvironment from multi-dimensional mechanisms to therapeutic strategies. Front Oncol Feng Y, Gu L, Jia Z, Zhang C, Zhu Z. PMID: 42559176 [PubMed]
	Marantic Endocarditis Presenting With Ischemic Stroke in Advanced Non-small Cell Lung Cancer: The Contribution of Fluorodeoxyglucose (FDG) PET/CT to the Differential Diagnosis of Valvular Vegetations. Cureus Bentama N, Bouchaala A, Mouine N, Lakhal Z, Benyass A. PMID: 42559156 [PubMed]
	Comparative safety signals of carboplatin and cisplatin in lung cancer: a pharmacovigilance study based on FAERS. Front Med (Lausanne) Yang J, Quan C, Zhao Z, Chen Y, Zhang J, Cai R, Sun G. PMID: 42558823 [PubMed]
	Efficacy and safety of immunotherapy combined with chemoradiotherapy in limited-stage small cell lung cancer: a systematic evaluation and meta-analysis of randomized controlled trials. Front Immunol Wang Y, Liu Y, Zhan N, Jin K, Qi L, Liu S. PMID: 42558713 [PubMed - indexed for MEDLINE]
	Inhibitor of DNA binding 1 in lung cancer and the tumor microenvironment: a testable hypothesis for malignant pleural effusion formation. Front Immunol She Y, Du Y, Chen Z. PMID: 42558564 [PubMed - indexed for MEDLINE]
	Redefining the concept of resectability in the landscape of perioperative treatments for lung cancer. Front Oncol Petrella F, Cara A, Cassina EM, Dell'Agosto J, Libretti L, Pirondini E, Raveglia F, Tuoro A. PMID: 42558266 [PubMed]
	Feasibility of routine clinical liquid-based cytology for lung cancer compact panel testing. Cancer Cytopathol Shinomiya Y, Hatanaka KC, Okumura A, Nange A, Yamamoto M, Azuma M, Marukawa K, Ishida Y, Shimizu T, Watanabe R, Hashimoto Y, Abiko M, Sato Y, Sakakibara-Konishi J, Kato T, Tanaka S, Hatanaka Y. PMID: 42557973 [PubMed - indexed for MEDLINE]
	Chemotherapy and Radiotherapy Regimens for Limited-Stage Small Cell Lung Cancer Treated With Accelerated Hyperfractionated Radiotherapy Combined With Chemotherapy: A Real-World Study. Cancer Med Zhao J, Yao J, Li Y, Bai Y, Liu C. PMID: 42557939 [PubMed - indexed for MEDLINE]
	How diverse therapeutic strategies reshape the tumor immune microenvironment in small cell lung cancer: from radiation to engineered immunotherapies. Biochem Pharmacol Han Z, Tong J, Feng Y, Zhu K, Han Y, Xiao X, Li Y, Xia S. PMID: 42556480 [PubMed - as supplied by publisher]
	Quality in Central Pathology Assessment in Pulmonary Carcinoid and Large Cell Neuroendocrine Carcinoma: A Systematic Review. Mod Pathol Heijboer FWJ, Scattolin D, Hillen LM, Speel EM, Derks JL, Dingemans AC, von der Thüsen JH. PMID: 42556470 [PubMed - as supplied by publisher]
	Exploring the role of diabetes and its interaction patterns with risk factors for lung cancer: A population-based retrospective cohort study. Cancer Epidemiol Yau STY, Hung CT, Leung EYM, Lee A, Yeoh EK. PMID: 42556250 [PubMed - as supplied by publisher]
	Efficacy and safety of immunotherapy in driver mutation-negative advanced non-small cell lung cancer: A systematic review and meta-analysis. Indian J Med Res Kumar J, Ganguly S, Kaur P, Raghav A, Pai K, Meena J, Goyal JP, Yadav J. PMID: 42555694 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of pirfenidone for patients with cancer and grade 2 or grade 3 radiation-induced lung injury: A modeling study. PLoS Med Pan QY, Wang YX, Tang XY, Hou Z, Dong BQ, Li QW, Chen BQ, Bai SM, Wu CF, Chen M. PMID: 42555672 [PubMed - indexed for MEDLINE]
	Comparison Between EGFR-TKI Efficacy in Early-Stage Non-small Cell Lung Cancer and Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. Lung Wang B, Yao Y, Chen Z, Wu R, Sun J, Li X, Xu X, Si Y, Liu H. PMID: 42554774 [PubMed - indexed for MEDLINE]
	Pooled safety profiles of bispecific antibodies targeting PD-1/CTLA-4 or PD-1/VEGF in non-small cell lung cancer: a systematic review and single-arm meta-analysis. J Egypt Natl Canc Inst Ma J, Zhao W. PMID: 42554769 [PubMed - indexed for MEDLINE]
	Comments on 'Survival by Detection Pathway in Patients With Lung Cancer: A Nationwide Descriptive Epidemiological Study in Japan'. Int J Cancer Matsuzaka M, Tanaka R. PMID: 42554108 [PubMed - as supplied by publisher]
	Phantom-based evaluation of radiomics feature stability for low-dose CT lung cancer screening. Front Endocrinol (Lausanne) Zheng S, Yang X, Wang H, Gao Z, Ye P, Wang W, Li W, Meng D, Zhang S, Zhang W, Liu H, Huang S, Zhang C, Wang J, Hao J, Cui X. PMID: 42553098 [PubMed - indexed for MEDLINE]
	Safety and efficacy of drug-eluting beads versus conventional bronchial arterial chemoembolization for lung cancer: a systematic review and meta-analysis. Front Oncol Gong Z, Liu Y, Song Y, Li X, Tian Y, Li J, Qi C. PMID: 42553077 [PubMed]

Artikel 1 - 20 / 162074

Seite 1 von 8104



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung